In patients with MS increased MIF levels are detected in the blood and CSF during relapse, and in the active rim of MS WM lesions (Meza-Romero et al., 2014; Benedek et al., 2015; Benedek et al., 2017; Vandenbark et al., 2021). The gene discussed is MIF; the disease is myeloid sarcoma.